Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs

被引:66
作者
Daughton, Christian G. [1 ]
机构
[1] US EPA, Div Environm Sci, Natl Exposure Res Lab, Las Vegas, NV 89119 USA
关键词
Drugs; Active pharmaceutical ingredients; Pharmacokinetics; Prescribing; Water pollution; Sustainable healthcare; PERSONAL CARE PRODUCTS; SEWAGE-TREATMENT PLANTS; WASTE-WATER; NATIONAL RECONNAISSANCE; UNITED-STATES; HUMAN HEALTH; PHARMACEUTICALS; REMOVAL; DISPOSITION; IMPACT;
D O I
10.1016/j.scitotenv.2014.06.013
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Active pharmaceutical ingredients (APIs) from the purchase and use of medications are recognized as ubiquitous contaminants of the environment. Ecological impacts can range from subtle to overt resulting from multi-generational chronic exposure to trace levels of multiple APIs (such as in the aquatic environment) or acute exposure to higher levels (such as with wildlife ingestion of improperly discarded waste). Reducing API entry to the environment has relied solely on conventional end-of-pipe pollution control measures such as wastewater treatment and take-back collections of leftover, unwanted drugs (to prevent disposal by flushing to sewers). An exclusive focus on these conventional approaches has ignored the root sources of the problem and may have served to retard progress in minimizing the environmental footprint of the healthcare industry. Potentially more effective and less-costly upstream pollution prevention approaches have long been considered imprudent, as they usually involve the modification of long-established norms in the practice of clinical prescribing. The first pollution prevention measure to be proposed as feasible (reducing the dose or usage of certain select medications) is followed here by an examination of another possible approach one that would rely on the excretion profiles of APIs. These two approaches combined could be termed eco-directed sustainable prescribing (EDSP) and may hold the potential for achieving the largest reductions in API entry to the environment largely by guiding prescribers' decisions regarding drug selection. EDSP could reduce API entry to the environment by minimizing the need for disposal (as a consequence of avoiding leftover, unwanted medications) and reducing the excretion of unmetabolized APIs (by preferentially prescribing APIs that are more extensively metabolized). The potential utility of the Biopharmaceutics Drug Disposition Classification System (BDDCS) is examined for the first time as a guide for API prescribing decisions by revealing relative API quantities entering sewage via excretion. Published by Elsevier B.V.
引用
收藏
页码:392 / 404
页数:13
相关论文
共 77 条
  • [1] A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States - I) Groundwater
    Barnes, Kimberlee K.
    Kolpin, Dana W.
    Furlong, Edward T.
    Zaugg, Steven D.
    Meyer, Michael T.
    Barber, Larry B.
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2008, 402 (2-3) : 192 - 200
  • [2] Sanitation: A Global Estimate of Sewerage Connections without Treatment and the Resulting Impact on MDG Progress
    Baum, Rachel
    Luh, Jeanne
    Bartram, Jamie
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2013, 47 (04) : 1994 - 2000
  • [3] The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development
    Benet, Leslie Z.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (01) : 34 - 42
  • [4] BDDCS Applied to Over 900 Drugs
    Benet, Leslie Z.
    Broccatelli, Fabio
    Oprea, Tudor I.
    [J]. AAPS JOURNAL, 2011, 13 (04): : 519 - 547
  • [5] Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewater
    Blair, Benjamin D.
    Crago, Jordan P.
    Hedman, Curtis J.
    Treguer, Ronan J. F.
    Magruder, Christopher
    Royer, L. Scott
    Klaper, Rebecca D.
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2013, 444 : 515 - 521
  • [6] The Growing Impact of Pediatric Pharmaceutical Poisoning
    Bond, G. Randall
    Woodward, Randall W.
    Ho, Mona
    [J]. JOURNAL OF PEDIATRICS, 2012, 160 (02) : 265 - U312
  • [7] Preventing Medication Overdoses in Young Children: An Opportunity for Harm Elimination
    Budnitz, Daniel S.
    Salis, Spencer
    [J]. PEDIATRICS, 2011, 127 (06) : E1597 - E1599
  • [8] Adult Prescription Drug Use and Pediatric Medication Exposures and Poisonings
    Burghardt, Lindsey C.
    Ayers, John W.
    Brownstein, John S.
    Bronstein, Alvin C.
    Ewald, Michele Burns
    Bourgeois, Florence T.
    [J]. PEDIATRICS, 2013, 132 (01) : 18 - 27
  • [9] Biopharmaceutical Classification Based on Solubility and Dissolution: A Reappraisal of Criteria for Hypothesis Models in the Light of the Experimental Observations
    Charkoftaki, Georgia
    Dokoumetzidis, Aristides
    Valsami, Georgia
    Macheras, Panos
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (03) : 168 - 172
  • [10] Rejection of Trace Organic Compounds by Forward Osmosis Membranes: A Literature Review
    Coday, Bryan D.
    Yaffe, Bethany G. M.
    Xu, Pei
    Cath, Tzahi Y.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2014, 48 (07) : 3612 - 3624